CTOs on the Move

Reliant Labs

www.reliantlabs.com

 
Reliant Labs is a Sunnyvale, CA-based company in the Computers and Electronics sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Cliff and Assoc

Cliff and Assoc is a South Pasadena, CA-based company in the Computers and Electronics sector.

Victron

With over 130,000 square feet of manufacturing capacity, Victron provides leading edge Electronic Manufacturing and Supply Chain Management services to a variety of leading Original Equipment Manufacturers (OEMs) in the communications, networking,

Xeal Energy

Xeal is a technology-first electric vehicle (EV) charging company operating at the intersection of mobility, real estate, IoT, and energy. We are building the next generation of EV charging solutions to take the market from 1% to 100% mass adoption. We tackle the world`s greatest challenges with disruptive, yet practical solutions for the built environment and future of smart cities. Xeal has been adopted by the nation`s largest real estate companies to electrify thousands of parking spaces.

INTrinsic Semiconductor

INTrinsic Semiconductor Corp. is a Sterling, VA-based company in the Computers and Electronics sector.

Xceleron

Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them.  We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.